Fenglin Cai

450 total citations
25 papers, 269 citations indexed

About

Fenglin Cai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Fenglin Cai has authored 25 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Fenglin Cai's work include Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Epigenetics and DNA Methylation (5 papers). Fenglin Cai is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers) and Epigenetics and DNA Methylation (5 papers). Fenglin Cai collaborates with scholars based in China and United States. Fenglin Cai's co-authors include Jinhai Tang, Jingyu Deng, Rupeng Zhang, Gang Ma, Lei Tang, Deyuan Fu, Pengliang Wang, Gang Ye, Han Liang and Qin Xiao and has published in prestigious journals such as Small, British Journal of Cancer and Experimental Cell Research.

In The Last Decade

Fenglin Cai

23 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenglin Cai China 10 159 101 81 57 27 25 269
Rongjie Zhao China 9 162 1.0× 102 1.0× 56 0.7× 60 1.1× 42 1.6× 21 279
Huanqiu Chen China 8 155 1.0× 110 1.1× 52 0.6× 46 0.8× 45 1.7× 18 236
Songliu Hu China 11 178 1.1× 97 1.0× 50 0.6× 75 1.3× 34 1.3× 21 278
Jun You China 10 149 0.9× 69 0.7× 95 1.2× 92 1.6× 57 2.1× 35 296
Rongfeng Song China 9 110 0.7× 71 0.7× 59 0.7× 49 0.9× 22 0.8× 16 225
Mingdian Lu China 9 198 1.2× 101 1.0× 50 0.6× 45 0.8× 15 0.6× 15 271
Xiaotao Jiang China 10 136 0.9× 116 1.1× 112 1.4× 41 0.7× 64 2.4× 25 283
Elvira Stacher‐Priehse Germany 7 102 0.6× 71 0.7× 105 1.3× 29 0.5× 24 0.9× 15 222
Shaozhang Zhou China 10 136 0.9× 123 1.2× 108 1.3× 140 2.5× 27 1.0× 23 290
Ziming Gao China 14 177 1.1× 101 1.0× 78 1.0× 64 1.1× 36 1.3× 29 337

Countries citing papers authored by Fenglin Cai

Since Specialization
Citations

This map shows the geographic impact of Fenglin Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglin Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglin Cai more than expected).

Fields of papers citing papers by Fenglin Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglin Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglin Cai. The network helps show where Fenglin Cai may publish in the future.

Co-authorship network of co-authors of Fenglin Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglin Cai. A scholar is included among the top collaborators of Fenglin Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglin Cai. Fenglin Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Yang, et al.. (2024). CLEC4D as a Novel Prognostic Marker Boosts the Proliferation and Migration of Gastric Cancer via the NF-κB/AKT Signaling Pathway. International Journal of General Medicine. Volume 17. 1923–1935. 1 indexed citations
3.
Deng, Wenbo, Fenglin Cai, Quan Shi, et al.. (2024). “One‐Pot” Synthesized Phosphorus Corrole‐Based Metal–Organic Frameworks for Synergistic Phototherapy and Chemodynamic Therapy. Small. 21(4). e2408975–e2408975. 4 indexed citations
4.
Cai, Fenglin, Gang Ma, Pengliang Wang, et al.. (2024). EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. British Journal of Cancer. 130(4). 597–612. 3 indexed citations
5.
Wang, Xiangyu, Fenglin Cai, Li Zhang, et al.. (2024). The Key Role of Tumor Budding in Predicting the Status of Lymph Node Involvement in Early Gastric Cancer Patients: A Clinical Multicenter Validation in China. Annals of Surgical Oncology. 31(7). 4224–4235. 3 indexed citations
6.
Ma, Gang, et al.. (2024). Ketohexokinase-A deficiency attenuates the proliferation via reducing β-catenin in gastric cancer cells. Experimental Cell Research. 438(1). 114038–114038. 1 indexed citations
7.
Zhang, Mengmeng, et al.. (2024). ACAT2 suppresses the ubiquitination of YAP1 to enhance the proliferation and metastasis ability of gastric cancer via the upregulation of SETD7. Cell Death and Disease. 15(4). 297–297. 9 indexed citations
9.
Li, Bin, Gang Ma, Fenglin Cai, et al.. (2023). Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells. Clinical Epigenetics. 15(1). 10–10. 10 indexed citations
10.
Zeng, Yi, Gang Ma, Fenglin Cai, et al.. (2023). SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner. Cell Death and Disease. 14(6). 386–386. 7 indexed citations
11.
Ma, Gang, Yi Sun, Fenglin Cai, et al.. (2023). DEPTOR as a novel prognostic marker inhibits the proliferation via deactivating mTOR signaling pathway in gastric cancer cells. Experimental Cell Research. 427(1). 113598–113598. 3 indexed citations
12.
Zhang, Nannan, Xiaoliang Gao, Qiangqiang Yuan, et al.. (2023). E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1. Clinical Epigenetics. 15(1). 77–77. 12 indexed citations
13.
Ma, Gang, Zhenzhen Zhao, Yang Qu, et al.. (2022). Cysteine dioxygenase 1 attenuates the proliferation via inducing oxidative stress and integrated stress response in gastric cancer cells. Cell Death Discovery. 8(1). 493–493. 14 indexed citations
14.
Dong, Yinping, Fenglin Cai, Pengliang Wang, et al.. (2021). Risk of station 12a lymph node metastasis in patients with lower-third gastric cancer. World Journal of Gastrointestinal Surgery. 13(11). 1390–1404. 1 indexed citations
15.
Cai, Fenglin, Yinping Dong, Pengliang Wang, et al.. (2021). Risk assessment of lymph node metastasis in early gastric cancer: Establishment and validation of a Seven-point scoring model. Surgery. 171(5). 1273–1280. 13 indexed citations
16.
Sun, Weilin, Gang Ma, Li Zhang, et al.. (2021). DNMT3A-mediated silence in ADAMTS9 expression is restored by RNF180 to inhibit viability and motility in gastric cancer cells. Cell Death and Disease. 12(5). 428–428. 22 indexed citations
17.
Yang, Jing, Dexi Liu, Fenglin Cai, et al.. (2021). Visual multiple cross displacement amplification for the rapid identification of S. agalactiae immediately from vaginal and rectal swabs. AMB Express. 11(1). 9–9. 2 indexed citations
19.
Peng, Hao, Meifang Wang, Ying Liu, et al.. (2020). Isoliquiritigenin inhibits TGF-<roman>β</roman>1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells. Acta Biochimica et Biophysica Sinica. 52(8). 810–820. 40 indexed citations
20.
Fu, Deyuan, et al.. (2015). Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer. Tumor Biology. 36(10). 8025–8034. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026